Measure 1.3
Project
As part of the project activities, the research organisation will carry out development work consisting of developing a solution aimed at improving the FlexiOss®Vet product. A two-stage study will be commissioned. After the first stage, it is planned to determine the release curve and to select antibiotics or bone fusion promoters for which the FlexiOss®Vet product can serve as a drug carrier. In the next stage, the most effective way to soak the composite will be tested, as well as determination of the amount of substance necessary for soaking, which would be an alternative to standard drug delivery.
Project objective
The aim of the project is to develop a solution to improve the bone substitute material FlexiOss®Vet so that it can be a drug carrier.
Planned results
The expected result of the work is a solution at technology readiness level IX, i.e. ready for implementation in Medical Inventi company’s operations. The improved product will have functional features that are attractive to the existing and new customers, and will be sold through existing distribution agreements, making the implementation of the work results likely to be a market success.
Project value: 338,250.00 PLN
Co-financing value: 233,750.00 PLN
#EUFunds #EuropeanFunds